Drug rescue is also termed as rescue medicines. These are given only when needed or in emergency cases. Drug which is given to counter or block the effect of other medicines are called as rescue medicines. Rescue medications are often used for asthma, in chemotherapy, in severe allergies, in epilepsy, etc. These are fast acting or quick acting medications. Rescue medicines are used in severe asthma attack, migraine attack, or in severe allergy reaction and help to save lives. In clinical trials, rescue medicines are given with a drug to control the alleviated symptoms of the study treatment or lack of disease efficiency. The effect of rescue drugs are not long lasting, but these quickly stop the symptoms of study drug.
The drug rescue market has been segmented based on drug class, indication, route of administration, and distribution channel. In terms of drug class, the market has been segmented into antiepileptics, analgesics, antinauseants, muscle relaxants, and bronchodilators.
Based on indication, the drug rescue market has been categorized into asthma, migraine, epilepsy, cancer, hypertension, cardiac attack, and others. Rescue medicines prevent asthma attack quickly. Bronchodilators are the generally used medication in asthma. Bronchodilators help open the airways by dilating the bronchi and enable a patient to breathe more easily. Migraine is another medical condition where rescue medications are widely used. Migraine attacks are disabling and severe. Several over-the-counter or prescription medicines are available to stop a migraine attack. Ibuprofen or acetaminophen or drugs containing caffeine are the most common rescue medicines for migraine.
Benzodiazepines are the most common rescue medicines for seizures or epilepsy attack. Benzodiazepine is a fast acting drug and starts work quickly once it gets into the bloodstream to prevent seizures. Benzodiazepines are available in different forms such chewing pills, oral tablet, or nasal sprays. The most common benzodiazepines used as rescue medications are diazepam, lorazepam, and midazolam. Intravenous treatment is given in hypertension and cardiac emergencies. These directly go into the bloodstream and 100% bioavailability can be achieved by intravenous route. Sodium nitroprusside, nitroglycerin, labetalol, and nicardipine are the commonly used drugs for hypertension.
In terms of route of administration, the drug rescue market has been segmented into oral, parenteral, sublingual, nasal, and rectal. Nasal route is the widely used route of administration for asthma and epilepsy attacks. Drugs given through nasal route have fast effect. The smaller mist particles directly go in systemic circulation and act quickly. Intravenous route is given in severe conditions when other route of administration do not work.
Based on distribution channel, the drug rescue market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies is widely used distribution channel as many over-the-counter rescue drugs are also available. Growth of the online pharmacies segment is likely to boost the market during the forecast period.
In terms of region, the drug rescue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the major share of the drug rescue market owing to increasing incidence of severe and chronic medical conditions. The rising geriatric population is also anticipated to boost the growth of the market during the forecast period. Asia Pacific is the most progressive region for the drug rescue market due to increasing over-the-counter rescue medicines in the region.
Major factor boosting the growth of this market include rising demand for quick treatment for severe medical conditions. However, the increasing side effects of rescue medicines is likely to restrain the drug rescue market.
Major players in the drug rescue market are Bioneer Corporation, VistaGen Therapeutics, Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industry Ltd., Merck & Co., Inc., and UCB Group of Companies.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.